SCHEMBL16745327

SCHEMBL16745327

c1ccc(P(c2ccccc2)c2cccc3c2OC24Oc5c(cccc5P(c5ccccc5)c5ccccc5)C[C@H]2CCC[C@@H]4C3)cc1

nearest known ligand 0.40

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17072557 1.00 DRD1 (0.40) DRD1
SCHEMBL16745328 1.00 DRD1 (0.40) DRD1
SCHEMBL16745301 0.97 DRD1 (0.40) DRD1
SCHEMBL16745297 0.94 DRD1 (0.46) DRD1
SCHEMBL17070585 0.93 DRD1 (0.39) DRD1
SCHEMBL17070586 0.93 DRD1 (0.39) DRD1
SCHEMBL16745512 0.93 DRD1 (0.36) DRD1
SCHEMBL16745279 0.93 DRD1 (0.39) DRD1
SCHEMBL16745566 0.93 DRD1 (0.36) DRD1
SCHEMBL16812574 0.93 DRD1 (0.39) DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022127320-A1 INTERMEDIATE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 四川大学 2022-06-23 WO claimed
CN-114423764-A Intermediate, preparation method and application thereof 四川大学 2022-04-29 CN claimed
CN-114423764-B Intermediate, preparation method and application thereof 四川大学 2023-03-17 CN disclosed
WO-2022127320-A1 INTERMEDIATE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 四川大学 2022-06-23 WO disclosed
CN-114423764-A Intermediate, preparation method and application thereof 四川大学 2022-04-29 CN disclosed
US-20200392150-A1 Diaryl-B-Lactam Compound and Preparation Method and Pharmaceutical Use Thereof FUDAN UNIVERSITY (CN) 2020-12-17 US disclosed
WO-2017167183-A1 DIARYL-Β-LACTAM COMPOUND AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF 复旦大学 2017-10-05 WO disclosed
US-9527862-B2 Compounds of chiral aromatic spiroketal diphosphine ligands, preparation methods and uses thereof SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2016-12-27 US disclosed
US-9527862-B2 Compounds of chiral aromatic spiroketal diphosphine ligands, preparation methods and uses thereof SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2016-12-27 US disclosed
US-9518014-B2 Process for synthesis of ezetimibe and intermediates used in said process SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2016-12-13 US disclosed
EP-2876102-B1 PROCESS FOR SYNTHESIS OF EZETIMIBE AND INTERMEDIATES USED IN SAID PROCESS SHANGHAI INST ORGANIC CHEMISTRY CAS (CN) 2016-12-07 EP disclosed
US-20150252055-A1 COMPOUNDS OF CHIRAL AROMATIC SPIROKETAL DIPHOSPHINE LIGANDS, PREPARATION METHODS AND USES THEREOF SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2015-09-10 US disclosed
US-20150252055-A1 COMPOUNDS OF CHIRAL AROMATIC SPIROKETAL DIPHOSPHINE LIGANDS, PREPARATION METHODS AND USES THEREOF SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2015-09-10 US disclosed
US-20150166479-A1 PROCESS FOR SYNTHESIS OF EZETIMIBE AND INTERMEDIATES USED IN SAID PROCESS SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2015-06-18 US disclosed
EP-2876108-A1 COMPOUNDS OF CHIRAL AROMATIC SPIROKETAL DIPHOSPHINE LIGANDS, PREPARATION METHODS AND USES THEREOF Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CN) 2015-05-27 EP disclosed
EP-2876102-A1 PROCESS FOR SYNTHESIS OF EZETIMIBE AND INTERMEDIATES USED IN SAID PROCESS Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CN) 2015-05-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166479-A1 PROCESS FOR SYNTHESIS OF EZETIMIBE AND INTERMEDIATES USED IN SAID PROCESS HMGCR, COASY, APOB DRD1 4195/4885
US-20200392150-A1 Diaryl-B-Lactam Compound and Preparation Method and Pharmaceutical Use Thereof PEPD, SQLE, BACE1 DRD1 3562/4885
US-20150252055-A1 COMPOUNDS OF CHIRAL AROMATIC SPIROKETAL DIPHOSPHINE LIGANDS, PREPARATION METHODS AND USES THEREOF DDT, DPYD, RECQL DRD1 566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.